Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
Department of Oncology, CREATE Health Strategic Center for Translational Cancer Research, Skane Department of Oncology, Lund University, Skane University Hospital, Lund, Sweden